MENAFN

(MENAFN) Guinea-Bissau has terminated a contentious hepatitis B vaccine trial bankrolled by the Trump administration following a sharp ethical rebuke from the World Health Organization (WHO), which warned the study risked causing irreversible harm...

MENAFN

(MENAFN) Guinea-Bissau has terminated a controversial hepatitis B vaccine study financed by the administration of US President Donald Trump after the World Health Organization raised ethical concerns about the project’s design.

EIN Presswire

On-the-ground investigation raised alarms about safeguards for children, conflicts of interest, and grant oversight.

EIN Presswire

Following WHO’s statement of concern, Stand Up For Science urges immediate action to halt unethical research practices.

Macao Government News

MACAU, June 5 - The Chief Executive, Mr Sam Hou Fai, today met in Macao with the President of the Republic of Guinea-Bissau, Mr Umaro Sissoco Embaló, to exchange views on enhancing Macao’s role as a platform between China and Portuguese-speaking...

GlobeNewswire, Inc.

HOUSTON, April 29, 2026 (GLOBE NEWSWIRE) -- Itafos Inc. (TSX-V: IFOS) (OTCQX: ITFS) (the “Company” or “Itafos”) today reported its Q1 2026 financial results and provided a corporate update.